On the same day another headline in the same paper said: "Haemophilia group welcomes 'landmark day'." However, in another part of the paper the questions were already beginning to be raised. Some degree of dissent was expressed by the Irish Haemophilia Society, which criticised the Department of Health and Children for aspects of its handling and indicated clearly it was disappointed that the report did not clearly put on record a finding that the BTSB did put profit ahead of safety in the treatment of its patients. A week later, the same paper is full of intense and detailed criticism of the report. In fact, it compares it very unfavourably in terms of both timescale and cost to other reports, particularly the Finlay report, which took a considerably shorter time to be issued and cost considerably less.